Thomas Jerome Lynch - 14 Feb 2021 Form 4 Insider Report for MedMen Enterprises, Inc. (MMNFF)

Role
CEO
Signature
/s/ Thomas Jerome Lynch
Issuer symbol
MMNFF
Transactions as of
14 Feb 2021
Transactions value $
$0
Form type
4
Filing time
05 Oct 2021, 19:34:52 UTC
Previous filing
05 Oct 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MMNFF Class B Subordinate Voting Shares Award $0 +1,258,322 +258% $0 1,746,135 14 Feb 2021 Direct F1, F2
transaction MMNFF Class B Subordinate Voting Shares Award $0 +850,036 +49% $0 2,596,171 29 Aug 2021 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MMNFF Employee Stock Options (right to buy) Award $0 +214,030 $0 214,030 29 Aug 2021 Class B Subordinate Voting Shares 214,030 $0.2814 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Issued pursuant to Issuer's 2018 Stock Incentive Plan.
F2 Represents restricted stock units ("RSUs"), which vest annually over four years beginning 6/30/2021, with 37.5% of shares vesting on 6/30/2021 and 6/30/2023, and 12.5% of shares vesting on 6/30/2022 and 6/30/2024. RSUs are equivalent to Issuer's Class B Subordinate Voting Shares and may be settled solely by delivery of an equal number of such shares of Issuer.
F3 Represents RSUs, which vest annually over four years beginning 6/30/2022, with 37.5% of shares vesting on 6/30/2022 and 6/30/2024, and 12.5% of shares vesting on 6/30/2023 and 6/30/2025. RSUs are equivalent to Issuer's Class B Subordinate Voting Shares and may be settled solely by delivery of an equal number of such shares of Issuer.
F4 Such options have an exercise price of CAN$0.355, which is equivalent to US$0.2814 at an exchange rate of 1.2635.